Trial · NCT00577720
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percent Change in Serum CTX (Type I Collagen C-telopeptide), ITT (Intent to Treat) Population | 35 mg IRBB (Immediate Release Before Breakfast) | -43.20 | 95% Confidence Interval -55.83 to -30.58 | Percent Change | |
| Percent Change in Serum CTX (Type I Collagen C-telopeptide), ITT (Intent to Treat) Population | 35 mg DRFB (Delayed Release Following Breakfast) | -62.08 | 95% Confidence Interval -73.59 to -50.56 | Percent Change | |
| Percent Change in Serum CTX (Type I Collagen C-telopeptide), ITT (Intent to Treat) Population | 50 mg DRFB | -65.11 | 95% Confidence Interval -77.70 to -52.52 | Percent Change | |
| Percent Change in Serum CTX (Type I Collagen C-telopeptide), ITT (Intent to Treat) Population | 50 mg DRBB (Delayed Release Before Breakfast) | -66.30 | 95% Confidence Interval -77.42 to -55.18 | Percent Change | |
| Percent Change in Urine NTX/Cr (Urine Type I Collagen Cross-linked N-telopeptide Corrected for Creatinine Clearance), ITT Population | 35 mg IRBB (Immediate Release Before Breakfast) | -38.57 | 95% Confidence Interval -56.60 to -20.54 | Percent Change | |
| Percent Change in Urine NTX/Cr (Urine Type I Collagen Cross-linked N-telopeptide Corrected for Creatinine Clearance), ITT Population | 35 mg DRFB (Delayed Release Following Breakfast) | -46.60 | 95% Confidence Interval -63.04 to -30.17 | Percent Change | |
| Percent Change in Urine NTX/Cr (Urine Type I Collagen Cross-linked N-telopeptide Corrected for Creatinine Clearance), ITT Population | 50 mg DRFB | -43.65 | 95% Confidence Interval -61.62 to -25.67 | Percent Change | |
| Percent Change in Urine NTX/Cr (Urine Type I Collagen Cross-linked N-telopeptide Corrected for Creatinine Clearance), ITT Population | 50 mg DRBB (Delayed Release Before Breakfast) | -54.27 | 95% Confidence Interval -70.14 to -38.40 | Percent Change | |
| Percent Change in Serum BAP (Bone-specific Alkaline Phosphatase), ITT Population | 35 mg IRBB (Immediate Release Before Breakfast) | -10.99 | 95% Confidence Interval -19.62 to -2.365 | Percent Change | |
| Percent Change in Serum BAP (Bone-specific Alkaline Phosphatase), ITT Population | 35 mg DRFB (Delayed Release Following Breakfast) | -10.41 | 95% Confidence Interval -18.28 to -2.545 | Percent Change | |
| Percent Change in Serum BAP (Bone-specific Alkaline Phosphatase), ITT Population | 50 mg DRFB | -20.00 | 95% Confidence Interval -28.60 to -11.40 | Percent Change | |
| Percent Change in Serum BAP (Bone-specific Alkaline Phosphatase), ITT Population | 50 mg DRBB (Delayed Release Before Breakfast) | -17.36 | 95% Confidence Interval -24.96 to -9.767 | Percent Change |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00577720/results